Kyle Dyson

Neuropathologist. Immunologist. Genome engineer.

I build engineered immune therapies for brain tumors — combining high-throughput genetic screens, CAR T-cell design, and translational biomarker work to move new treatments from bench to clinic.

Currently a neuropathology fellow and postdoctoral researcher at Stanford, working in the laboratories of Theo Roth and Michelle Monje.